These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 3082496

  • 1. Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women.
    González D, Ghiringhelli G, Mautalen C.
    Calcif Tissue Int; 1986 Feb; 38(2):71-5. PubMed ID: 3082496
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease.
    González D, Vega E, Ghiringhelli G, Mautalen C.
    Calcif Tissue Int; 1987 Dec; 41(6):313-5. PubMed ID: 3124939
    [Abstract] [Full Text] [Related]

  • 3. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC, Meunier P, Terrier M, David L, Vignon G.
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [Abstract] [Full Text] [Related]

  • 4. Acute effect of the intranasal administration of salmon calcitonin in osteoporotic women.
    Vega E, Gonzalez D, Ghiringhelli G, Mautalen C.
    Bone Miner; 1989 Nov; 7(3):267-73. PubMed ID: 2611446
    [Abstract] [Full Text] [Related]

  • 5. [Induced hypocalcaemia test using salmon calcitonin as a means for the evaluation of osteoclastic activity (author's transl)].
    Blanc D, Chapuy MC, Meunier P.
    Nouv Presse Med; 1989 Nov; 6(28):2489-94. PubMed ID: 562508
    [Abstract] [Full Text] [Related]

  • 6. [A test for acute hypocalcemia using swine and salmon calcitonin].
    Fournié A, Valverde C, Tap G, Bazerque JJ, Ayrolles C.
    Rev Rhum Mal Osteoartic; 1977 Feb; 44(2):91-8. PubMed ID: 847364
    [Abstract] [Full Text] [Related]

  • 7. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S, Rosenberg E, Haddad JG.
    Lancet; 1974 Dec 14; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract] [Full Text] [Related]

  • 8. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC, Harrison JE, Wilson DR.
    Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231
    [Abstract] [Full Text] [Related]

  • 9. Effect of salmon calcitonin on cardiac output, oxygen transport and bone turnover in patients with Paget's disease.
    Crosbie WA, Mohamedally SM, Woodhouse NJ.
    Clin Sci Mol Med Suppl; 1975 Jun 05; 48(6):537-40. PubMed ID: 1056285
    [Abstract] [Full Text] [Related]

  • 10. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F, Baker RK, Wallach S.
    J Clin Invest; 1971 Sep 05; 50(9):1927-40. PubMed ID: 4935444
    [Abstract] [Full Text] [Related]

  • 11. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A, Nuti R, Vattimo A, Galli M, Turchetti V, Franci B, Martorelli T, Righi G.
    Minerva Med; 1983 Apr 28; 74(18):993-1010. PubMed ID: 6087215
    [Abstract] [Full Text] [Related]

  • 12. Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.
    Hamilton CR.
    Am J Med; 1974 Mar 28; 56(3):315-22. PubMed ID: 4855941
    [No Abstract] [Full Text] [Related]

  • 13. [Intermittent treatment of Paget's disease of bone with calcitonin: histological study].
    Eisinger J, Laponche AM.
    Rev Rhum Mal Osteoartic; 1976 Mar 28; 43(7-9):511-6. PubMed ID: 981933
    [Abstract] [Full Text] [Related]

  • 14. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A.
    Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428
    [Abstract] [Full Text] [Related]

  • 15. Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment.
    Avramides A, Flores A, DeRose J, Wallach S.
    J Clin Endocrinol Metab; 1976 Mar 23; 42(3):459-63. PubMed ID: 1254686
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of Paget's disease with salmon calcitonin].
    Manderlier T, Fuss M, Brauman J, Orloff S, Bergans A, Corvilain J.
    Rev Rhum Mal Osteoartic; 1977 Jan 23; 44(1):59-66. PubMed ID: 319520
    [No Abstract] [Full Text] [Related]

  • 17. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD, Chapuy MC, Meunier PJ.
    Horm Metab Res; 1984 May 23; 16(5):258-61. PubMed ID: 6234216
    [Abstract] [Full Text] [Related]

  • 18. [Long-term therapy with calcitonin in Paget's diseases (author's transl)].
    Schmidt UJ, Trzenschik K, Abendroth K, Graner H, Ansorg A.
    Z Alternsforsch; 1978 May 23; 33(2):173-83. PubMed ID: 100975
    [Abstract] [Full Text] [Related]

  • 19. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K, Schmidt UJ, Abendroth K, Ansorg H, Graner H, Lindenhayn K, Schramm G, Kalbe I.
    Z Alternsforsch; 1978 May 23; 33(5):441-51. PubMed ID: 570764
    [Abstract] [Full Text] [Related]

  • 20. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S, Cepollaro C, Montomoli M, Gennari L, Montagnani A, Palmieri R, Gennari C.
    Clin Endocrinol (Oxf); 1997 Jan 23; 46(1):55-61. PubMed ID: 9059558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.